161 related articles for article (PubMed ID: 26898741)
21. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
22. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
23. Polymer-drug conjugates: recent progress on administration routes.
Pang X; Yang X; Zhai G
Expert Opin Drug Deliv; 2014 Jul; 11(7):1075-86. PubMed ID: 24758250
[TBL] [Abstract][Full Text] [Related]
24. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
25. Responsive polymer conjugates for drug delivery applications: recent advances in bioconjugation methodologies.
Ferreira Soares DC; Oda CMR; Monteiro LOF; de Barros ALB; Tebaldi ML
J Drug Target; 2019 Apr; 27(4):355-366. PubMed ID: 30010436
[TBL] [Abstract][Full Text] [Related]
26. Polymeric conjugates for drug delivery.
Larson N; Ghandehari H
Chem Mater; 2012 Mar; 24(5):840-853. PubMed ID: 22707853
[TBL] [Abstract][Full Text] [Related]
27. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
28. Polymer-drug conjugates as modulators of cellular apoptosis.
Vicent MJ
AAPS J; 2007 Jun; 9(2):E200-7. PubMed ID: 17907762
[TBL] [Abstract][Full Text] [Related]
29. Polymer therapeutics: concepts and applications.
Haag R; Kratz F
Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
[TBL] [Abstract][Full Text] [Related]
30. Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview.
Javia A; Vanza J; Bardoliwala D; Ghosh S; Misra LA; Patel M; Thakkar H
Int J Pharm; 2022 Jul; 623():121863. PubMed ID: 35643347
[TBL] [Abstract][Full Text] [Related]
31. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
[TBL] [Abstract][Full Text] [Related]
32. Polymer-drug conjugates in inflammation treatment.
Koziolová E; Venclíková K; Etrych T
Physiol Res; 2018 Oct; 67(Suppl 2):S281-S292. PubMed ID: 30379550
[TBL] [Abstract][Full Text] [Related]
33. Controlled Radical Polymerization as an Enabling Approach for the Next Generation of Protein-Polymer Conjugates.
Pelegri-O'Day EM; Maynard HD
Acc Chem Res; 2016 Sep; 49(9):1777-85. PubMed ID: 27588677
[TBL] [Abstract][Full Text] [Related]
34. Polymer Based Protein Therapeutics.
Bhawani SA; Husaini A; Ahmad FB; Asaruddin MR
Curr Protein Pept Sci; 2018; 19(10):972-982. PubMed ID: 28828988
[TBL] [Abstract][Full Text] [Related]
35. Polymer therapeutics-prospects for 21st century: the end of the beginning.
Duncan R; Vicent MJ
Adv Drug Deliv Rev; 2013 Jan; 65(1):60-70. PubMed ID: 22981753
[TBL] [Abstract][Full Text] [Related]
36. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
Duncan R; Ringsdorf H; Satchi-Fainaro R
J Drug Target; 2006 Jul; 14(6):337-41. PubMed ID: 17092834
[No Abstract] [Full Text] [Related]
37. PEGylated polymers for medicine: from conjugation to self-assembled systems.
Joralemon MJ; McRae S; Emrick T
Chem Commun (Camb); 2010 Mar; 46(9):1377-93. PubMed ID: 20162127
[TBL] [Abstract][Full Text] [Related]
38. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
39. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
40. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
Chytil P; Koziolová E; Etrych T; Ulbrich K
Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
